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Kristofer M. Charlton-Ouw, MD, Anthony L. Estrera, MD, Hazim J. Saﬁ, MD, and Ali Azizzadeh, MD,
Houston, Tex
Background: Thoracic endovascular aortic repair (TEVAR) is widely used for treatment of traumatic aortic injury (TAI).
Stent graft coverage of the left subclavian artery (LSA) may be required in up to 40% of patients. We evaluated the long-
term effects of intentional LSA coverage (LSAC) on symptoms and return to normal activity in TAI patients compared
with a similarly treated group whose LSA was uncovered (LSAU).
Methods: Patients were identiﬁed from a prospective institutional trauma registry between September 2005 and July 2012.
TAI was conﬁrmed using computed tomography angiography. The electronic medical records, angiograms, and computed
tomography angiogramswere reviewed in a retrospective fashion. In-person or telephone interviewswere conductedusing the
SF-12v2 (Quality Metrics, Lincoln, RI) to assess quality of life. An additional questionnaire was used to assess speciﬁc LSA
symptoms and the ability to return to normal activities. Data were analyzed by Spearman rank correlation andmultiple linear
and logistic regression analysis with appropriate transformations using SAS software (SAS Institute, Cary, NC).
Results: During the study period, 82 patients (57 men; mean age 40.5 6 20 years, mean Injury Severity Score, 34 6 10.0)
underwentTEVAR for treatment ofTAI. Among them, LSACwas used in 32 (39.5%) andLSAU in 50.A group of the LSAU
patients (n [ 22) served as matched controls in the analysis. We found no statistically signiﬁcant difference in SF-12v2
physical health scores (r[L0.08; P[ .62) between LSAC and LSAU patients. LSAC patients had slightly better mental
health scores (r[ 0.62; P[ .037) than LSAU patients. LSAC patients did not have an increased likelihood of experiencing
pain (r[L0.0056; P[ .97), numbness (r[L0.12; P[ .45), paresthesia (r[L0.11; P[ .48), fatigue (r[L0.066;
P[ .69), or cramping (r[L0.12;P[ .45).We found nodifference between groups in the ability to return to activities. The
mean follow-up time was 3.35 years. Six LSAC patients (19%) died during the follow-up period of unrelated causes.
Conclusions: Intentional LSAC during TEVAR for TAI appears safe, without compromising mental or physical health
outcomes. Furthermore, LSAC does not increase the long-term risk of upper extremity symptoms or impairment of
normal activities. (J Vasc Surg 2015;61:73-9.)Traumatic aortic injury (TAI) is the second most com-
mon cause of death after blunt trauma, surpassed only by
head injuries.1,2 Thoracic endovascular aortic repair
(TEVAR) has become the treatment of choice for anatom-
ically suitable patients with TAI because meta-analyses have
demonstrated that it results in less mortality, paraplegia,
stroke, and spinal cord ischemia (SCI) compared with
open repair.3,4 The most common location for blunt aorticthe Department of Cardiothoracic and Vascular Surgery, University of
exas Medical School at Houston, and Memorial Hermann Heart &
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://dx.doi.org/10.1016/j.jvs.2014.05.099injury is at the isthmus, and left subclavian artery coverage
(LSAC) is required in up to 40% of patients.5,6
There is a paucity of data addressing the long-term
outcomes of patients requiring LSAC during TEVAR for
TAI. The necessity of left subclavian artery revasculariza-
tion is debated in the literature. The current Society for
Vascular Surgery (SVS) Clinical Practice Guidelines suggest
selective revascularization as an appropriate treatment strat-
egy for patients undergoing TEVAR for TAI.7 However,
there is a growing body of evidence that revascularization
may be beneﬁcial in patients undergoing LSAC for aneu-
rysmal disease. Whether these data extrapolate to TAI pa-
tients is unclear. The present study was performed to
evaluate the long-term outcomes of intentional LSAC in
patients with TAI who undergo TEVAR.
METHODS
The Committee for the Protection of Human Subjects,
the local Institutional Review Board, approved this study
with a waiver of consent. Data on patients with TAI who
underwent TEVAR were prospectively collected from the
institutional trauma registry at our level 1 trauma center
between September 2005 and July 2012.73
Fig 1. A, Diagnostic and (B) completion angiogram of a patient who underwent thoracic endovascular aortic repair
(TEVAR) with left subclavian artery coverage (LSAC) for traumatic aortic injury (TAI).
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& Associates, Flagstaff, Ariz) was approved by the United
States Food and Drug Administration (FDA) for repair of
thoracic aortic aneurysms. We started performing TEVAR
for patients with TAI with the off-label use of the TAG de-
vice. Owing to available device diameter limitations, the
TEVAR procedure could only be offered to patients with
aortic diameters >23 mm. Two smaller devices, Talent
(Medtronic, Santa Rosa, Calif) and TX2 (Cook Medical,
Bloomington, Ind), were approved in 2008, facilitating
the treatment of patients with smaller aortic diameter in
an off-label fashion. The Food and Drug Administration
subsequently approved the CTAG (W. L. Gore) and
Valiant (Medtronic) devices for on-label use of isolated le-
sions, including TAI, in 2012.
Our treatment algorithm has been previously
described.6 TAI cases were identiﬁed using computed to-
mography angiography (CTA) and grouped into one of
four grades by severity. Grade I is characterized by an
intimal tear, with no involvement of the media and no con-
tour abnormalities to the outside surface of the aorta.
Grade II is an injury that extends to the media, such as
an intramural hematoma or dissection, with the presence
of an external contour abnormality. Grade III is an aortic
pseudoaneurysm, and grade IV is free rupture.6 Grade I in-
juries were managed medically with anti-impulse therapy
using b-blockers and a follow-up CTA in 6 weeks to ensure
healing of the lesion. Grades II and III were considered for
urgent repair with TEVAR. Grade IV underwent emer-
gency repair.
We tailored the timing of repair to each patient by the
grade of the aortic injury, the presence and severity of asso-
ciated injuries, and the patient’s overall physiologic status.
In general, urgent TEVAR for stable grade II and III pa-
tients was done within 24 to 48 hours of admission. Pa-
tients with grade IV injuries were taken directly to the
operating room from the emergency department foremergency repair. In addition, patients with traumatic
brain injury required more immediate intervention because
they are not suitable candidates for anti-impulse therapy.
LSAC was used where necessary to achieve a 20 mm
proximal seal zone, as recommended by the manufacturer’s
instructions for use. Patients who were not anatomically
suitable for TEVAR underwent open repair and were not
a part of our present analysis. Contraindications to TEVAR
would include injuries that involve the ascending aorta or
transverse arch, anatomy that is prohibitive for device deliv-
ery, and allergies to device components.
TEVAR procedures were performed in a hybrid oper-
ating room equipped with ﬁxed imaging equipment
(Axiom; Siemens Medical, Malvern, Pa). Patients were un-
der general anesthesia with the abdomen and bilateral
groins prepared. An arch angiogram was performed before
the procedure to further delineate the injury and evaluate
cerebrovascular anatomy (Fig 1, A). Patients were anticoa-
gulated with heparin using a weight-based protocol
(1 mg/kg) or a smaller dose of 3000 to 5000 units. Pa-
tients with associated injuries who were at high risk of
bleeding, such as those with intracranial hemorrhage or
solid organ injury, received the smaller dose of heparin.
The device was delivered and deployed without phar-
macologic adjunct. A postdeployment arch angiogram
was performed (Fig 1, B). Balloon angioplasty was per-
formed selectively if a type I endoleak was apparent. We
maintained a policy of selective delayed subclavian artery
revascularization. Patients were returned to the intensive
care unit after TEVAR and were discharged after other in-
juries they incurred were stabilized. Follow-up CTAs were
performed at 1, 6, and 12 months, and yearly thereafter to
exclude complications.
For the purpose of the quality of life study, patients were
grouped into two treatment arms: thosewho required LSAC
and those whose LSA was uncovered (LSAU). A group of
matched controls, according to the Injury Severity Score
Table. Baseline characteristics for patients included in the study
Parameter
Mean for
PLSAC LSAU All surveyed
Age, years 53.69 6 22.3 36.77 6 16.6 46.7 6 21.7 <.004
ISS 32.3 6 9 36.8 6 10.7 34.3 6 9.8 .13
GCS 10.0 6 5.5 10.4 6 5.4 10.2 6 5.4 .95
RPS 0.71 6 0.27 0.76 6 0.29 0.73 6 0.28 .53
TAI gradea (IQR) 3 (3-3) 3 (2-3) 3 (3-3) .52
Device diameter, mma (IQR) 26 (22-28) 25 (22-26) 25 (22-28) .16
Length of stay, days
Intensive care unit 14.24 6 12.9 13.86 6 16.5 14.08 6 14.4 .49
Total hospital 22.6 6 21.4 23.8 6 19.4 23.2 6 20.4 .82
Time since TEVAR, years 3.23 6 2.1 3.67 6 2.44 3.46 6 2.2 .32
GCS, Glasgow Coma Scale; IQR, interquartile range; ISS, Injury Severity Score; LSAC, left subclavian artery coverage; LSAU, left subclavian artery uncovered;
RPS, Revised Probability of Survival; TAI, traumatic aortic injury; TEVAR, thoracic endovascular aortic repair.
aMedian reported.
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Survival (RPS), and TAI grade, were selected from the
LSAU arm to ensure comparability of the two groups. In-
person or telephone interviews were conducted using the
SF-12v2 instrument (Quality Metrics, Lincoln, RI) to assess
quality of life. The physical and mental health scores gener-
ated by the SF-12v2 were both used in our analysis.
An additional survey was conducted concerning inci-
dence of symptoms and ability to return to normal activities
in the postoperative period. Patients were asked if they
experienced paresthesia, numbness, tingling, pain, cramp-
ing, or weakness in the left arm in excess of the right to
screen for symptoms related to LSAC. If symptoms were
present, patients indicated the duration that symptoms
lasted in the postoperative period. In addition, patients
were asked about their normal activities before TEVAR
and whether they felt they were impaired in their perfor-
mance of those activities after the procedure. If impairment
was present, patients were asked to rate their level of
impairment on a graded scale.
For the LSAC group, perioperative CTAs were
reviewed to measure bilateral vertebral artery size to assess
predictive value for presence and duration of symptoms.
Patients with right vertebral arteries (RVAs) with greater
diameter than the left were said to be RVA dominant,
and the size of the RVA in excess of the left vertebral artery
(LVA) was used in our analysis. During an in-ofﬁce follow-
up visit, wrist-brachial indices were performed to measure a
relationship among a reduction in segmental pressures with
symptoms, activity impairment, and quality of life.
Data were analyzed by Spearman rank correlation
and multiple linear and logistic regression analysis with
appropriate transformations using SAS 9.3 software (SAS
Institute, Cary, NC).
RESULTS
During the study period, 82 patients (57 men; mean
age, 40.5 6 20 years; mean ISS, 34 6 10.0) underwent
TEVAR for TAI. Among them, 32 (39.5%) required
LSAC. A group of 22 LSAU patients served as matched(ISS, GCS, RPS, and TAI grade) controls. For the 54 pa-
tients included in this analysis, ISS, GCS, TAI grade, device
diameter, intensive care unit length of stay, and total hos-
pital length of stay are provided in the Table. The midterm
outcomes of this cohort have been previously published.5
Six of the LSAC patients expired during the follow-up
period. We were able to contact 18 of the remaining 26
patients. Eight patients (31%) were lost to follow-up.
We found no statistically signiﬁcant difference in the
SF-12v2 physical health scores between LSAC and LSAU
patients (r ¼ 0.08; P ¼ .62). The LSAC patients had
slightly better mental health scores on the SF-12v2
(r ¼ .62; P ¼ .037). As expected, impairment of activities
and presence of symptoms were both negatively correlated
with SF-12v2 physical and mental health scores, as charac-
terized in the Supplementary Table (online only). We
could identify no statistically signiﬁcant difference in the
ability to return to normal activities or in the incidence of
postoperative symptoms between LSAC and LSAU pa-
tients, as displayed in Figs 2 and 3, respectively. Mean tele-
phone interview follow-up time was 3.46 years (standard
deviation, 1.9 years) for the entire cohort.
Three of the 18 patients (17%) in the LSAC group were
left-handed, whereas only one of the 22 patients (4.5%) in
the LSAU group was left-handed. Vertebral artery measure-
ments from intraoperative arch angiograms showed
increasing RVA dominance was negatively correlated with
the incidence of numbness (r¼ 0.62; P¼ .02). No associ-
ation was found among a reduction in peak systolic velocity
and SF-12v2 scores, symptoms, or impairment of activities.
Two carotid-subclavian bypasses were performed for
reﬂex sympathetic dystrophy and atherosclerotic vertebral
artery disease on postoperative days 75 and 1821, respec-
tively. The clinical course of these two patients has been
previously published.5 Six LSAC patients died during the
follow-up period. Two of the deaths (a 62-year-old man
and an 80-year-old woman) were in patients who had
had a stroke (one preoperative and one postoperative).
An 85-year-old woman died of complications of hemor-
rhagic shock after splenectomy. A 62-year-old man died
Fig 2. Percentage of patients with activity impairment in the postoperative period. LSAC, Left subclavian artery
covered; LSAU, left subclavian artery uncovered.
Fig 3. Incidence of left upper extremity symptoms in the postoperative period. LSAC, Left subclavian artery covered;
LSAU, left subclavian artery uncovered.
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3 months after TEVAR. An 80-year-old woman died
61 days after TEVAR secondary to the severity of the asso-
ciated injuries. Finally, an 87-year-old man died 1544 days
after TEVAR of natural causes.
DISCUSSION
The societal burden of TAI is signiﬁcant. Recent au-
topsy studies show up to one-third of deaths after motor
vehicle accidents involve TAI.8 According to the 2010 Na-
tional Vital Statistics Report, an estimated 12,533 of the
total 37,661 deaths may have involved TAI.1 Motorvehicle accidents, especially involving a head-on collision,
cause >70% of all TAIs,2,9 and 80% of these individuals
die at the scene.10 Of the patients who survive to be eval-
uated in a hospital, up to 50% die #24 hours of arrival.11
Because TAI is a common and serious traumatic injury,
an understanding of which treatment strategies reduce
death and long-term complications to the greatest degree
is of utmost importance.
In 2011, the SVS released practice guidelines for the
use of TEVAR for TAI to help standardize care and
make suggestions on case management based on the avail-
able evidence.7 A meta-analysis assimilating data from 139
JOURNAL OF VASCULAR SURGERY
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TEVAR reduced mortality compared with open repair of
TAI from 19% to 9% (P < .01).4 The SVS subsequently
developed guidelines for the optimal use of TEVAR,
including the suggestion that selective revascularization
based on the status of vertebrobasilar anatomy be used to
minimize the potential increased risk associated with the
routine performance of carotid-subclavian bypass. It is
noteworthy that this recommendation was not made based
on the meta-analysis but was founded on data consisting of
case series, expert opinion, and observational studies. Addi-
tional research is warranted to more adequately deﬁne
optimal selection criteria for bypass procedures after LSAC.
It is clear that a subset of patients is likely to beneﬁt
from subclavian revascularization. Several large studies
have demonstrated an increased incidence of adverse
neurologic events, such as stroke and SCI, in nonrevascu-
larized patients compared with those routinely revascular-
ized. A meta-analysis from 2009 comparing LSAC with
LSAU patients found statistically signiﬁcant increases in
left arm and vertebrobasilar ischemia in the LSAC group,
along with an increased risk of SCI and anterior circulation
stroke that were not statistically signiﬁcant.12
Buth et al,13 analyzing data from the European Collab-
orators on Stent-Graft Techniques for Abdominal Aortic
Aneurysm Repair (EUROSTAR) registry, found that
routine revascularization reduced the risk of stroke and
SCI compared with nonrevascularized patients (P ¼
.049). This study constitutes one of the larger experiences
with TEVAR but is based on a self-reported and noncon-
secutive registry of patients.13 A meta-analysis that
included the EUROSTAR data as a heavily weighted
contributor also found an increased risk of stroke (from
2.7% in revascularized to 4.7% in nonrevascularized) and
risk of SCI (from 2.3% revascularized to 2.8% nonrevascu-
larized), which was statistically signiﬁcant (P ¼ .005 for
both ﬁndings). Revascularization was statistically protective
for SCI, but not stroke.14 Importantly, these analyses all
included TEVAR patients treated for a variety of aortic pa-
thology, with only a subset of these patients treated for
TAI. This limits the applicability of the conclusions to out-
comes of TAI patients, who may have a different long-term
prognosis as a group.
A second procedure to revascularize the LSA is not
without risk. Reported complications include injury to
the thoracic duct, vagus nerve, phrenic nerve, subclavian
vein, subclavian artery, and sympathetic nerves resulting
in Horner syndrome.15,16 Takach et al17 reported a stroke
risk of 2.1% during a 50-year experience with these revascu-
larization procedures. Because of the documented risks
associated with subclavian revascularization, several groups
began to investigate the utility of selectively revasculariza-
tion only in those patients whose symptoms after LSAC
dictated the need for the second procedure.
Lee et al18 published their single-institution experience
supporting a strategy of selective revascularization. These in-
vestigators found no statistically signiﬁcant difference be-
tween revascularized and nonrevascularized patients inmortality (6.3% vs 1.8%; P ¼ .21), paraplegia (3.1% vs 0%;
P¼ .22), or stroke (3.1% vs 3.5%;P> .99). In addition, three
of 32 (9.3%) revascularized patients developed complica-
tions from the procedure, emphasizing again that this proce-
dure is not without inherent risks that must be considered.
A recent single-institution retrospective study found no
difference in neurologic outcomes with and without revas-
cularization after TEVAR.19 These results were consistent
with the ﬁndings of Woo et al,20 who followed a protocol
of selective revascularization and identiﬁed no statistically
signiﬁcant difference in stroke rate with and without revas-
cularization (7% vs 11%, respectively; P ¼ .6) when such a
policy was used.
Lastly, Maldonado et al21 produced the largest multi-
center TEVAR experience in the literature by using data
from six tertiary care centers. No signiﬁcant difference
was demonstrated between revascularized and nonrevascu-
larized patients in SCI (4.1% vs 7.5%; P ¼ .2) and stroke
(6.4% vs 6.1%; P ¼ .9).
As in these studies supporting routine revasculariza-
tion, TAI was not a speciﬁc focus of these studies, limiting
their applicability in aortic pathology of strictly traumatic
etiology. Our stroke rate was similar to publications con-
cerning TEVAR.22
The identiﬁcation of risk factors for symptoms after
LSAC will allow caregivers to better select good candidates
for the procedure. The 2011 SVS practice guidelines iden-
tify angiography of the RVA as the measure that can prob-
ably be most expeditiously assessed in an emergency.7 In
one small study, Lee et al23 could not identify an associa-
tion between hypoplasia of the RVA or LVA dominance
with SCI or stroke as long as both vertebral arteries were
patent. The same study found a trend of progressive
RVA hypertrophy in TEVAR patients during the postoper-
ative follow-up period. Seven of 27 LSAC patients (25.9%)
presented with this ﬁnding, with contrast-enhanced CT of
their mean RVA diameter increasing from 3.5 6 0.9 to
4.7 6 0.9 mm during a 36-month interval. This may indi-
cate that at least in a subset of patients, the RVA may
respond with hypertrophy as a compensation mechanism
for retrograde LVA ﬂow after LSAC.
Antonello et al24 performed a similar analysis of verte-
bral anatomy and found that side of dominance was not an
important predictor of postoperative symptoms. However,
no hypoplastic vertebral arteries (as deﬁned by a diameter
of <2 mm) were identiﬁed in the study patients.24 Our
analysis of vertebral artery anatomy and symptomatology,
however, revealed that increasing RVA dominance was
negatively correlated with presence of numbness
(r ¼ 0.66; P ¼ .02). Further investigation of vertebroba-
silar anatomy and its relationship to symptoms may prove
useful in the selection of good candidates for LSAC and
determining the probability that revascularization will be
required.
Left arm ischemia has been presented as a concern for
LSAC without revascularization by a number of re-
searchers.19,24,25 Although these investigators have re-
ported the incidence of left arm ischemia in their
JOURNAL OF VASCULAR SURGERY
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estimate the effect of those symptoms on patient-
reported quality of life. Our use of the SF-12v2 represents
the ﬁrst analysis using tools designed to directly measure
quality of life in long-term follow-up for LSAC patients.
Because we found no long-term difference in quality of
life and ability to maintain normal activities, the beneﬁt
that patients with normal vertebrobasilar anatomy experi-
ence from revascularization may prove to be minimal
compared with the risk for complications.
Previous studies have focused on incidence of symp-
toms in LSAC patients without regard to severity. Howev-
er, mild symptoms that cause no impairment may not
warrant further surgical intervention. In addition, future
commercial thoracic aortic stent grafts will incorporate
branched technology, allowing for subclavian revasculariza-
tion during the index procedure.
Limitations to this investigation include its single-center
participation, which may limit the general applicability to all
TAI patients. This study also involves a relatively small
cohort. However, the literature is lacking studies with large
patient populations speciﬁcally focused on TEVAR with
LSAC for TAI. Although power may be a concern owing
to the small cohort, we investigated the expected relation-
ship among quality of life scores, symptoms, and activity
impairment and found a statistical association. This implies
any residual effects of LSAC on quality of life would be
less signiﬁcant than these relationships (Supplementary
Table, online only). In addition, there was loss to follow-
up as described in the Results. This loss to follow-up is sig-
niﬁcant, but is comparable to our past experience with
follow-up compliance in trauma patients.26,27
CONCLUSIONS
Intentional coverage of the LSA during TEVAR for
TAI appears safe, without compromising mental or physical
health outcomes. Furthermore, LSAC does not appear to
increase the long-term risk of upper extremity symptoms
or impairment of normal activities. Because TEVAR is
now the treatment of choice for amenable patients with
TAI, a more complete understanding of the consequences
of intentional LSAC will prove beneﬁcial in assessment of
potential risk and beneﬁt for individual cases. Although
follow-up in trauma patient groups remains a challenge,
more research is needed to better understand long-term
outcomes of LSAC.
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at www.jvascsurg.org.DISCUSSIONDr W. Anthony Lee (Boca Raton, Fla). Good morning. I
would like to thank the Program Committee for the privilege of
discussing this paper and the authors for sending me a copy of
the manuscript way in advance of the meeting.
The manuscript is well written and the topic should be of in-
terest to this audience. The advent of thoracic endovascular aortic
repair (TEVAR) has forced vascular surgeons to recognize that the
left subclavian artery is not some vestigial vessel that can be indis-
criminately covered without consequences. Despite the relatively
large body of literature addressing the need for left subclavian
revascularization during TEVAR, including a recently published
Society for Vascular Surgery (SVS) Clinical Practice Guidelines,
opinions remain sharply divided.
Extrapolation of what we knew about left subclavian physi-
ology from occlusive disease clearly did not apply in patients
with an acutely occluded left subclavian artery during TEVAR.
Acute occlusion has been associated with arm ischemia, posterior
circulation stroke, and spinal cord ischemia. The reasons behind
the inconsistent presentations stem from a combination of the var-
iable collateral circulation of the left subclavian artery, some of
which share their blood supply with the central nervous system,
the right-handed dominance of most of the human population,
and the asymmetry of vertebral anatomy.
In the paper just presented, the authors share their large expe-
rience in repair of traumatic aortic injuries spanning 7 years and
report on the subset of those who underwent TEVAR, speciﬁcally
addressing the issue of the impact on the quality of life after left
subclavian artery coverage. This is a difﬁcult subset of patients in
whom to conduct a quality of life study especially in the context
of associated injuries that may impact left arm function that is
not discoverable through a single metric such as the Injury Severity
Score. It is with this confounding background the results should be
interpreted. I have a few questions for the authors:
1. Who conducted the interviews? Did a single person conduct
them or multiple?
2. How many of the covered and uncovered subjects in the study
were left-handed? No data are presented regarding this impor-
tant functional parameter, which can affect how the results are
interpreted.
3. “Mental health score”–why would coverage of left subclavian
artery result in an improvement in this outcome measure? Or
is this simply a result of statistical mining?4. Please expound on the relevance of right vertebral anatomy, in
terms of size and dominance, as it relates left arm function.
5. In the one patient who had a perioperative posterior circula-
tion stroke, was his or her subclavian covered or uncovered?
And if covered, was it revascularized eventually? The word
“perioperative” is unclear. When did it occur exactly? Preop
or postop?
Once again thank you for the privilege of discussing this
paper.
Cameron McBride. Dr Lee, thank you for those questions.
They address some important points. Let me start with the ques-
tion about the authors. Two authors worked together to create
the protocol for the questionnaire, and those same two authors
were the ones who carried out the interviews.
In regard to the left- and right-handedness of the patients, it
was asked about during the survey process; however, it was not
part of our analysis, and I do not have that information available
today. In future studies, it will be a point of interest because we un-
derstand its importance.
With the mental health scores, we do not give any particular
importance to the fact that the mental health scores were better
in the covered group, and we would like to see that replicated in
future studies before we say that is a clinically meaningful ﬁnding.
With the patient who had the stroke, the reason the word peri-
operatively was used was because it was somewhat unclear when
the stroke happened. The patient was under general anesthesia,
and the symptoms were noticed when she woke up, so it is difﬁcult
to determine exactly when the patient had the stroke. It is possible
that the stroke was intraoperative.
In response to the right vertebral artery (RVA) anatomy:
Because after the left subclavian artery is covered the right vertebral
becomes the main supply to the posterior circulation of the brain,
and via retrograde ﬂow through the left vertebral also to the left
arm, we suspected that people with larger RVAs would be better
able to compensate after the coverage. The same was thought
about RVA dominance, because those that are right vertebral
dominant before the coverage occurs do not have as large of a
disturbance to the vertebrobasilar junction after coverage, so we
suspected that that group would be able to compensate better as
well. However, because those with large RVAs are more likely to
be right vertebral dominant, it could be that that is just a reitera-
tion of the size ﬁnding.
Supplementary Table (online only). Correlations of
SF-12v2a scores with symptoms and impairment
SF-12v2 Measure of impairment
Correlation
coefﬁcient P
Physical
health
Presence of paresthesia 0.28 .03
Duration of paresthesia 0.35 .03
Presence of numbness 0.31 .05
Duration of numbness 0.39 .01
Presence of fatigue 0.36 .02
Duration of fatigue 0.36 .02
Impairment of leisure activities 0.62 <.0001
Impairment of physical labor 0.68 .0001
Impairment of cardiovascular
exercise
0.38 .03
Impairment of resistance training 0.76 .0001
Impairment of child/elderly care 0.55 .02
Impairment of hobbies 0.82 <.0001
Impairment of sports 0.78 .002
Impairment of housework 0.68 <.0001
Mental
health
Presence of paresthesia 0.30 <.01
Duration of paresthesia 0.39 .01
Presence of numbness 0.47 <.01
Duration of numbness 0.47 <.01
Presence of fatigue 0.32 .04
Duration of fatigue 0.31 .05
Impairment of physical labor 0.53 .005
Impairment of cardiovascular
exercise
0.67 <.0001
Impairment of resistance training 0.61 .006
Impairment of child/elderly care 0.52 .03
Impairment of hobbies 0.54 .01
Impairment of sports 0.63 .02
Impairment of housework 0.52 .0008
aQuality Metrics, Lincoln, RI.
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